Silverfin false false 31/05/2024 31/05/2024 01/06/2023 The principal activity of the Company during the financial year was specialists medical practice activities. Amanda Braybrooke 27/05/2020 Dr Jeremy Braybrooke 27/05/2020 12624341 2024-05-31 12624341 bus:Director1 2024-05-31 12624341 bus:Director2 2024-05-31 12624341 2023-05-31 12624341 core:CurrentFinancialInstruments 2024-05-31 12624341 core:CurrentFinancialInstruments 2023-05-31 12624341 2023-06-01 2024-05-31 12624341 bus:Micro-entities 2023-06-01 2024-05-31 12624341 bus:FilletedAccounts 2023-06-01 2024-05-31 12624341 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 12624341 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 12624341 bus:Director1 2023-06-01 2024-05-31 12624341 bus:Director2 2023-06-01 2024-05-31 12624341 2022-06-01 2023-05-31 iso4217:GBP xbrli:pure

Company No: 12624341 (England and Wales)

BRISTOL ONCOLOGY LIMITED

Unaudited Financial Statements
For the financial year ended 31 May 2024
Pages for filing with the registrar

BRISTOL ONCOLOGY LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 31 May 2024

Contents

BRISTOL ONCOLOGY LIMITED

BALANCE SHEET

As at 31 May 2024
BRISTOL ONCOLOGY LIMITED

BALANCE SHEET (continued)

For the financial year ended 31 May 2024
2024 2023
£ £
Fixed assets 56,531 1,859
Current assets 181,752 172,001
Prepayments and accrued income - 500
Creditors: amounts falling due within one year ( 15,882) ( 25,734)
Net current assets 165,870 146,767
Total assets less current liabilities 222,401 148,626
Accruals and deferred income ( 1,453) ( 1,393)
Net assets 220,948 147,233
Capital and reserves 220,948 147,233

For the financial year ending 31 May 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Bristol Oncology Limited (registered number: 12624341) were approved and authorised for issue by the Board of Directors on 06 December 2024 and were signed on its behalf by:

Dr Jeremy Braybrooke
Director
BRISTOL ONCOLOGY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2024
BRISTOL ONCOLOGY LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 31 May 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 12624341). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including directors 2 2